

Leptospirosis is a bacterial disease caused by Leptospira bacteria. These bacteria are spiral in shape, which is reflected in their name. In humans, this disease spreads through direct or indirect contact with the urine of infected animals or contaminated water or soil.
The Leptospira - IgM antibody test helps identify IgM antibodies, typically produced by the immune system in the early stages (within 4 to 7 days after symptom onset) of leptospirosis infection.
Leptospirosis causes symptoms like high-grade fever, sudden headache, nausea/vomiting, loss of appetite, and muscle pain. These flu-like symptoms often lead to misdiagnosis as dengue, hepatitis, or regular flu. The Leptospira - IgM antibody test is vital for diagnosing leptospirosis in individuals presenting with these symptoms. Early diagnosis and proper treatment can help prevent serious complications like kidney or liver failure, heart problems, meningitis, etc.
No special preparation is required for the Leptospira - IgM antibody test. However, clinical history and details of recent exposure, like travel or floodwater contact, should be narrated to a doctor to help them correlate laboratory and clinical findings. It is important to inform the doctor about all medications, supplements, or underlying illnesses, as these factors can affect the test results.
Laboratory test results may vary across laboratories. Do not self-medicate and always consult a doctor to understand the test results correctly. In some cases, repeat testing or additional confirmatory tests may be warranted to ensure accuracy, or confirm a diagnosis before starting treatment.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The Leptospira - IgM antibody test measures the levels of IgM antibodies in the blood that are produced by the body in response to Leptospira bacteria. A positive test result may signal a recent or current infection, while a negative result may either mean absence of infection or testing too early before antibodies are detectable. In some cases, repeat testing or additional confirmatory tests (like Leptospira MAT) may be warranted.
The Leptospira - IgM antibody test is done:
- To diagnose early-stage leptospirosis by identifying Leptospira-specific IgM antibodies.
- To support diagnosis in individuals with symptoms of acute febrile illness after potential exposure.
- To differentiate leptospirosis from other illnesses causing similar symptoms (e.g., dengue, malaria, typhoid).
- To guide timely treatment and prevent complications.
- Clinical history is preferred.

































